Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Actuarial Approach01:20

Actuarial Approach

135
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
135
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

4.0K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transdiagnostic behavioral and sociodemographic influences on the cognitive-adaptive functioning gap in neurodivergent children.

Scientific reports·2026
Same author

Practice Patterns and Care Gaps in Lennox Gastaut Syndrome: A call for Action.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Selective Serotonin Reuptake Inhibitors for Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.

Clinical medicine insights. Pediatrics·2026
Same author

Smartphone videos for infantile epileptic spasms triaging and assessment (VISTA study): Impact of education and standardized clinical history on diagnostic accuracy.

Epilepsia open·2026
Same author

Diagnosis and management guidelines for infantile epileptic spasms syndrome around the world: A scoping review and comparative study of international approaches.

Epilepsia·2026
Same author

Navigating safety and sudden unexpected death in epilepsy (SUDEP) discussions in adolescents with epilepsy: short-term outcomes of a structured counselling intervention.

Epilepsy & behavior : E&B·2026

相关实验视频

Updated: Sep 11, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

结核性硬化综合症的死亡率:当前的理解

Rowan Pentz1, Lauren Sham2, Maria Zak2

  • 1Division of Neurology, Department of Paediatrics, McMaster University, Hamilton, ON, Canada.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
|August 15, 2025
PubMed
概括
此摘要是机器生成的。

结核性硬化综合体 (TSC) 的死亡率较高,这是一个遗传性疾病. 中枢神经系统和脏疾病是TSC患者的主要死亡原因.

关键词:
血管肌脂瘤是一种血管肌脂瘤.淋巴结核病是淋巴结核病.死亡率 死亡率 死亡率这就是SEGA SEGA.在 SUDEP 里面,你会发现坦德·坦德是什么意思结核性硬化综合体 结核性硬化综合体

更多相关视频

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K

相关实验视频

Last Updated: Sep 11, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K

科学领域:

  • 遗传学与医学 遗传学与医学
  • 神经科学是一个神经科学.
  • 在瘤学瘤学.

背景情况:

  • 结核性硬化综合体 (TSC) 是一种由TSC1和TSC2瘤抑制基因突变引起的遗传疾病.
  • TSC导致瘤的形成,造成严重的健康风险和高死亡率.
  • 最近的研究重点是确定TSC患者死亡的特定原因.

研究的目的:

  • 批判性地审查有关结核性硬化综合体死亡原因的现有文献.
  • 确定TSC患者的主要死亡原因和预期寿命.

主要方法:

  • 使用PubMed和谷歌学者进行了全面的文献审查.
  • 搜索术语包括"TSC"",结核性硬化综合体"",死亡率"",死亡"和"预期寿命".
  • 分析了13项研究的数据,包括6735名TSC个体和411例死亡.

主要成果:

  • 在TSC中,原始死亡率在每100个人中从1.4到13.8不等.
  • 标准化死亡率表明,TSC患者的死亡风险比对照患者高3.0至4.9倍.
  • TSC患者的平均预期寿命为66.2年,明显低于一般人群的81.8年.
  • 中枢神经系统和脏疾病是最常见的死亡原因 (85%的研究).
  • 淋巴细胞结核病和心脏狂犬病分别是成年妇女和新生儿死亡的重要原因.
  • 与TSC相关的神经精神疾病相关的死亡率可能被低估.

结论:

  • 与普通人群相比,结核性硬化综合体的死亡率显著增加.
  • 中枢神经系统和脏疾病是TSC死亡的主要驱动因素.
  • 需要进一步的研究,包括队列研究,以充分描述死亡风险,特别是新兴的疾病修饰疗法.